天士力 (600535)
Tasly Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 149395.00
- Circulating A-Shares(W): 149395.00
- Earnings Per Share(RMB): 0.6600
- Net Assets Per Share(RMB): 8.2362
- Operating Revenue(W RMB): 631067.29
- Total Profit(W RMB): 115275.34
- **Net Profit Attributable to Parent(W RMB) **: 98437.32
- Net Profit Growth Rate(%): 16.88
- Weighted Return on Equity(%): 8.0600
- Operating Cash Flow Per Share(RMB): 0.5840
- Undistributed Profit Per Share(RMB): 5.7073
- Capital Reserve Per Share(RMB): 0.3162
2. Main Business
The main business covers:
- Modern Chinese Medicine
- Biopharmaceuticals
- Chemical Drugs
3. Company Basic Information
- Company Name: Tasly Pharmaceutical Group Co., Ltd.
- Listing Date: 2002-08-23
- Industry: Pharmaceutical Manufacturing
- Address: No.2 Pujihe East Road, Beichen District, Tianjin (Tasly Modern Chinese Medicine City)
- Website: https://www.taslypharma.com
- Company Profile: Tianjin Tasly Pharmaceutical Co., Ltd. was approved by the Tianjin Municipal People's Government (Document No. Jin Gu Pi [2000] No. 4) on April 27, 2000, and was established through the overall transformation of Tianjin Tasly Pharmaceutical Group Co., Ltd. into a joint stock company. After the establishment of the joint stock company, the original shareholders of Tianjin Tasly Pharmaceutical Group Co., Ltd. - Tianjin Tasly Group Co., Ltd., Guangzhou Tianhe Zhenkai Trading Co., Ltd., Tianjin Tianshili Pharmaceutical Research and Development Co., Ltd., Tianjin New Technology Industrial Park Yongsheng Construction Co., Ltd., Jinhua Jinpan Development Zone Wanshun Trading Co., Ltd., Zhejiang Jianfeng Group Co., Ltd., and Tianjin Central Pharmaceutical Co., Ltd. - became shareholders of the joint stock company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | General Legal Person | 41830.60 | 28.00 |
| 2 | Tasly Biopharmaceutical Industry Group Co., Ltd. | General Legal Person | 25716.45 | 17.21 |
| 3 | Guoxin Investment Ltd. | Special Legal Person | 7469.75 | 5.00 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 4710.82 | 3.15 |
| 5 | CSI 500 Exchange Traded Fund | Fund | 1096.18 | 0.73 |
| 6 | Yinhua CSI Innovative Drug Industry ETF | Fund | 738.23 | 0.49 |
| 7 | Suzhou Liansheng Chemical Co., Ltd. | General Legal Person | 702.53 | 0.47 |
| 8 | Qianhai Kaiyuan Chinese Medicine Research Selected Stock Initiating Fund Class A | Fund | 361.83 | 0.24 |
| 9 | Changsheng Healthcare Industry Quantitative Allocation Stock Fund Class A | Fund | 60.35 | 0.04 |
| 10 | Changsheng Pension Health Industry Flexible Allocation Mixed Fund Class A | Fund | 53.60 | 0.04 |
5. Concept Sectors
- Biological Vaccines
- Generic Drugs
- Industrial Hemp
- Cold Chain Logistics
- Hepatitis Concept
- Innovative Drugs
- Margin Trading & Securities Lending
- High-Performance Stocks
- Shareholding in New Listings
- Spin-off Listing
- Control Change
- SSE Governance
- Small Cap Value
- SZSE Value Index
- CCTV 50
- CSI Central Enterprises
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information